N 696

Known as: N-696 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2006
012319822006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Vasorelaxant and hypotensive effects of tilisolol hydrochloride (N-696) in isolated rat thoracic aorta and pithed rats were… (More)
Is this relevant?
1988
1988
The effects of a new beta-blocker, (+/-)-4-(3-tert-butylamino-2-hydroxypropoxy)-2-methyl-1(2H)-isoquinolino ne hydrochloride… (More)
Is this relevant?
1988
1988
Six weeks of treatment with carvedilol, N-696, celiprolol, dilevalol, acebutolol, urapidil, doxazosin and altiopril reduced blood… (More)
Is this relevant?
1985
1985
4-[3-(tert-Butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696) is a new beta-adrenoceptor blocking drug… (More)
Is this relevant?
1985
1985
To characterize the alpha 1-adrenoceptors in the dog aorta and the rat brain and to assess the antagonistic potencies of various… (More)
Is this relevant?
1984
1984
We evaluated antiarrhythmic effects of N-696 using canine digitalis ventricular arrhythmia models and electrophysiological… (More)
Is this relevant?
1984
1984
To characterize the pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N… (More)
Is this relevant?
1984
1984
To assess the beta-blocking potencies of three newly synthesized beta-blockers, i.e., S-596: dl-2-(3'-t-butylamino-2… (More)
Is this relevant?
1983
1983
We determined the minimum effective plasma concentrations of several antiarrhythmic agents against canine halothane-adrenaline… (More)
Is this relevant?
1982
1982
Seven drugs were tested for their antiarrhythmic effects on ventricular arrhythmias 24 and 48 hr after two-stage coronary… (More)
Is this relevant?